Genomics Market Size, Share & Trends Analysis Report By Technology & Application, By Deliverables, End Use, By Region And Segment Forecasts From 2022 To 2030

The global genomics market size is projected to reach USD 94.9 billion by 2030, registering a CAGR of 16.4% during the forecast period from 2022 to 2030. The growing demand for novel therapeutic and research applications in genomics is indicative of global growth. Factors such as increasing demand for gene therapy, drug discovery, customized medicines, and a rise in cancer cases all around the world have positively impacted the genomics market.

Technological advancements like research on chromosomal instability and gene signatures that utilize unique samples from colossal databases emit a comprehensive understanding of their clinical applicability in the genomics market. The growing prevalence of genetic or inherited cancers is predicted to expand the demand for cancer genomics. The expansion of the genomics market is also dependent upon extensive research and development strategies that are carried out by biopharmaceutical companies for the discovery of drugs and evolution in personalized medicines that are technologically enabled.

Genomics was highly challenged by the COVID-19 pandemic in terms of research and therapeutics. However, the people significantly utilized few niche applications during the pandemic to immediately change focus to designing effective diagnostics and therapeutics, and steps to reduce the outspread of the COVID-19 virus. Several programs based on genomic surveillance were launched by different countries to understand the vitals of the pandemic situation and adopt effective precautionary methods.

The major market players are adopting expansion strategies like acquisitions, collaborations, partnerships, and huge capital investments for the advancements in research in genomics to understand unusual diseases and to assist in drug discovery. The genomics market is widely driven by lucrative support and opportunities from the governments along with various other research organizations for research advancements in the genome sequence. Currently, the focus on funds for data-driven initiatives in order to draw helpful outcomes from genome sequence research for the treatment of cancers, infectious diseases, rare diseases, and inherited disorders is increasing extensively.

Genomics Market Report Key Takeaways

• The growth of the genomics market globally is based upon the increasing dependence on novel therapeutics for genetic disorders and cancers on genomics-based understanding
• Owing to the rising demand for diagnostic and gene therapy applications, in 2021 functional genomics registered the largest market share
• 2021 market was dominated by North America owing to the presence of the major market players increasing support from the government and research institutes for the advancements in regional research on genomics
• Medical Device Innovation Consortium in August 2022 launched a somatic reference sample initiative to aid the enhancement of NGS-based cancer diagnostics by developing clinically relevant samples and public genomic datasets
• Thermo Fisher Scientific collaborated with Qatar Genome Program from the Qatar foundation in May 2022 to accelerate the research efforts in genomics

Genomics Market Segments

• Genomics Application & Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Functional Genomics
    • Real-Time PCR
    • Transfection
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
    • RNA Interference
  • Epigenomics
    • Bisulfite Sequencing
    • Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
    • Methylated DNA Immunoprecipitation (MeDIP)
    • High Resolution Melt (HRM)
    • Chromatin Accessibility Assays
    • Microarray Analysis
  • Pathway Analysis
    • Microarray Analysis
    • Bead-Based Analysis
    • Real-time PCR
    • Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
  • Biomarker Discovery
    • DNA Sequencing
    • Microarray Analysis
    • Real-time PCR
    • Mass Spectrometry
    • Statistical Analysis
    • Bioinformatics
  • Others
• Genomics Deliverables Outlook (Revenue, USD Million, 2018 - 2030)
  • Products
    • Instruments/Systems/Software
    • Consumables & Reagents
  • Services
    • Core Genomics services
    • NGS-based Services
    • Biomarker Translational Services
    • Computational Services
    • Others
• Genomics End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Clinical Research
  • Academic & Government Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users
• Genomics Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
• List of Key Players of Genomics Market
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • BGI Genomics
  • Color Genomics, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc.
  • 23andMe, Inc